Premium
Not Any New Functional Polymer Can Be for Medicine: What About Artificial Biopolymers?
Author(s) -
Vert Michel
Publication year - 2011
Publication title -
macromolecular bioscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 105
eISSN - 1616-5195
pISSN - 1616-5187
DOI - 10.1002/mabi.201100224
Subject(s) - biocompatibility , drug delivery , polymer , nanotechnology , biochemical engineering , gene delivery , tissue engineering , natural polymers , computer science , biomedical engineering , materials science , genetic enhancement , chemistry , medicine , engineering , gene , biochemistry , metallurgy , composite material
Man‐made artificial organic polymers are among the more recent sources of materials used by humans. In medicine, they contribute to applications in surgery, dentistry and pharmacology. Nowadays, innovations in the field of therapeutic polymers rely on novel polymers for specific applications such as guided tissue regeneration, tissue engineering, drug delivery systems, gene transfection, etc. Introducing reactive chemical functions within or along polymer backbones is an attractive route to generate functional polymers for medicine. However, any candidate to effective application must fulfil a number of requirements, grouped under the terms biocompatibility and biofunctionality, to be of real interest and have a future for effective application. Whenever the application requires a therapeutic aid for a limited period of time to help natural healing, bioresorbability is to be taken into account on top of biocompatibility and biofunctionality. This contribution presents the case of “artificial biopolymers” and discusses the potential of some members of the family with respect to temporary therapeutic applications that require functional polymers.